我要投票 中智药业在医疗器械行业中的票数:189
· 外 推 电 报 ·
2025-04-04 06:06:46 星期五

【中智药业是哪个国家的品牌?】

中智药业是什么牌子?「中智药业」是 中山市中智药业集团有限公司 旗下著名品牌。该品牌发源于广东省中山市,在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中智药业品牌出海!通过在本页面挂载中智药业品牌的产品链接和联系邮箱,可以提高中智药业产品曝光!跨境电商爆单神器,目前只要100元/年哦~

创办于1993年,拥有中智制药/恒生药业/中智中药饮片/中智大药房连锁等子公司,集中成药/中药饮片/保健品科研/生产与销售为一体


中智药业集团创办于1993年,集中成药、中药饮片、保健品科研、生产与销售为一体,拥有中智制药、恒生药业、中智中药饮片、中智大药房连锁四家子公司,拥有多个中药GAP种植研发基地和工程技术中心,药品生产经营产业链完善。

中智药业集团现有两大高科技生产基地,科研、生产能力和后续发展能力极强,拥有颗粒、胶囊、片剂、茶剂、口服液等剂型。目前,集团公司共有以“克咳片”为核心的中成药品种70多个,其中,包括有“石岐外感颗粒”、“小儿七星茶口服液”等品种7个,以及国家中药保护品种“金鸡颗粒”、“金鸡片”2个,全部医保品种16个。以第四代中药饮片——中药超微粉体为基础再创新升级的科技产品——破壁粉粒系列,是中智的科技品牌产品,拥有多项自主知识产权。以破壁粉粒产品为代表的“创新中药”系列产品,包括配方饮片、广东凉茶、药膳汤料、袋泡茶系列共有品种100多个。

中智药业集团紧跟国家中医药产业发展的方针政策,不遗余力的推进企业“精粹国药旗舰工程”的建设,依托生产、销售、营销服务和品牌打造等优势,企业正步上高科技发展之路。


英文翻译:Founded in 1993, it has subsidiaries such as China intelligent pharmaceutical / Hengsheng pharmaceutical / China intelligent Chinese Herbal Pieces / China intelligent pharmacy chain, and China intelligent Pharmaceutical Group is founded in 1993, integrating research, production and sales of ready-made medicine / Chinese Herbal Pieces / health care products, and integrating research, production and sales of ready-made medicine, Chinese herbal pieces, and health care products. It has China intelligent pharmaceutical, Hengsheng pharmaceutical, China intelligent Chinese herbal pieces, and China intelligent The pharmacy chain has four subsidiaries, multiple gap planting R & D bases and engineering technology centers for traditional Chinese medicine, and a complete pharmaceutical production and operation industry chain. At present, CIIC Pharmaceutical Group has two high-tech production bases with strong scientific research, production capacity and follow-up development capacity. It has such dosage forms as granules, capsules, tablets, tea agents and oral liquids. At present, the group has more than 70 varieties of Chinese patent medicine with Keke tablet as the core, including 7 varieties such as Shiqi waigan granule, xiaoerqixing tea oral liquid, 2 National Traditional Chinese medicine protection varieties such as Jinji granule and Jinji tablet, and 16 medical insurance varieties. Based on the fourth generation of decoction pieces of traditional Chinese Medicine - ultra micro powder of traditional Chinese medicine, the new and upgraded technology product - broken wall powder series, is a technology brand product of CIIC, with a number of independent intellectual property rights. There are more than 100 series of "innovative traditional Chinese medicine" products represented by broken wall powder and granule products, including formula pieces, Guangdong herbal tea, medicated diet soup and tea bag series. CIIC Pharmaceutical Group keeps up with the national policies and guidelines for the development of traditional Chinese medicine industry, spare no effort to promote the construction of the enterprise's "national medicine flagship project". Relying on the advantages of production, sales, marketing services and brand building, the enterprise is on the road of high-tech development.

本文链接: https://www.waitui.com/brand/dc1334ec1.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美国2月贸易逆差1227亿美元

美国商务部普查局4月3日发布数据,2月贸易逆差1227亿美元,预估为逆差1235亿美元,前值为逆差1314亿美元。(界面)

7分钟前

美股大型科技股盘前普跌,苹果跌超7%

36氪获悉,美股大型科技股盘前普跌,截至发稿,苹果、亚马逊跌超7%,特斯拉、Arm、英伟达跌超6%,Meta跌超5%,谷歌跌超4%,微软、奈飞跌超3%。

7分钟前

热门中概股美股盘前普跌,拼多多跌超6%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超6%,京东跌超5%,百度、爱奇艺、阿里巴巴、B站、蔚来跌超3%,理想汽车跌超2%,网易、腾讯音乐、微博跌超1%。

7分钟前

高测股份:控股股东张顼拟询价转让4.99%股份

36氪获悉,高测股份公告,公司控股股东张顼计划通过询价转让方式转让27,308,000股,占公司总股本的4.99%,转让原因为自身资金需求。出让方声明所持股份权属清晰,不存在限制或禁止转让情形,且不违反相关减持规定和承诺。本次询价转让的受让方需为具备相应定价能力和风险承受能力的机构投资者。本次询价转让的价格下限不低于发送认购邀请书之日(即2025年4月3日)前20个交易日高测股份股票交易均价的70%。

7分钟前

欧盟成员国拟表决对美关税反制措施

欧盟高级官员4月3日表示,欧盟成员国计划9日投票表决针对美方25%钢铝关税的反制措施。欧盟委员会负责贸易和经济安全等事务的委员马罗什·谢夫乔维奇表示,不合理的关税最终只会适得其反,欧盟将以冷静、有步骤且团结一致的方式作出回应。(新华社)

7分钟前

本页详细列出关于仁和可立克的品牌信息,含品牌所属公司介绍,仁和可立克所处行业的品牌地位及优势。
咨询